Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
International Clinical Psychopharmacology
|
April 30, 1999
Carbamazepine as an adjunct in the treatment of schizophrenia-like psychosis related to cannabis abuse
F M Leweke, H M Emrich
Current Topics in Medicinal Chemistry
|
September 25, 2013
Repurposed drugs for the treatment of schizophrenia and bipolar disorders
J M Bumb, F Enning, F M Leweke
The British Journal of Psychiatry : the Journal of Mental Science
|
January 25, 2000
Manic episode due to gabapentin treatment
F M Leweke, J Bauer, C E Elger
Pharmacopsychiatry
|
March 2, 2006
Systems-theory of psychosis--the relevance of "internal censorship"
H M Emrich, F M Leweke, U Schneider
Pharmacology, Biochemistry, and Behavior
|
April 1, 1997
Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system
H M Emrich, F M Leweke, U Schneider
Pharmacopsychiatry
|
April 21, 2007
Cessation of complex visual hallucinations during treatment with mirtazapine
D Koethe, T Dietl, F M Leweke, et al.
Pharmacopsychiatry
|
May 20, 2008
Improvement of general symptoms in a chronic psychotic patient treated with finasteride: case report
D Koethe, M Bortolato, D Piomelli, et al.
Epilepsy Research
|
August 1, 1990
Effects of pentetrazol on neuronal activity and on extracellular calcium concentration in rat hippocampal slices
F M Leweke, J Louvel, G Rausche, et al.
Frontiers in Pharmacology
|
November 24, 2016
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence
Cathrin Rohleder, Juliane K Müller, Bettina Lange, et al.
Fortschritte Der Neurologie-Psychiatrie
|
June 24, 2004
[AWMF-guideline: disorders related to cannabis]
U Bonnet, K Harries-Hedder, F M Leweke, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
International Clinical Psychopharmacology
|
April 30, 1999
Carbamazepine as an adjunct in the treatment of schizophrenia-like psychosis related to cannabis abuse
F M Leweke, H M Emrich
Current Topics in Medicinal Chemistry
|
September 25, 2013
Repurposed drugs for the treatment of schizophrenia and bipolar disorders
J M Bumb, F Enning, F M Leweke
The British Journal of Psychiatry : the Journal of Mental Science
|
January 25, 2000
Manic episode due to gabapentin treatment
F M Leweke, J Bauer, C E Elger
Pharmacopsychiatry
|
March 2, 2006
Systems-theory of psychosis--the relevance of "internal censorship"
H M Emrich, F M Leweke, U Schneider
Pharmacology, Biochemistry, and Behavior
|
April 1, 1997
Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system
H M Emrich, F M Leweke, U Schneider
Pharmacopsychiatry
|
April 21, 2007
Cessation of complex visual hallucinations during treatment with mirtazapine
D Koethe, T Dietl, F M Leweke, et al.
Pharmacopsychiatry
|
May 20, 2008
Improvement of general symptoms in a chronic psychotic patient treated with finasteride: case report
D Koethe, M Bortolato, D Piomelli, et al.
Epilepsy Research
|
August 1, 1990
Effects of pentetrazol on neuronal activity and on extracellular calcium concentration in rat hippocampal slices
F M Leweke, J Louvel, G Rausche, et al.
Frontiers in Pharmacology
|
November 24, 2016
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence
Cathrin Rohleder, Juliane K Müller, Bettina Lange, et al.
Fortschritte Der Neurologie-Psychiatrie
|
June 24, 2004
[AWMF-guideline: disorders related to cannabis]
U Bonnet, K Harries-Hedder, F M Leweke, et al.
Page
of 4